Literature DB >> 35578090

Perihematomal Edema and Clinical Outcome After Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

Sarah Marchina1, Jorge A Trevino-Calderon2, Sara Hassani3, Joseph M Massaro4, Vasileios-Arsenios Lioutas3, Filipa Carvalho3, Magdy Selim3.   

Abstract

BACKGROUND: Perihematomal edema (PHE) has been proposed as a radiological marker of secondary injury and therapeutic target in intracerebral hemorrhage (ICH). We conducted a systematic review and meta-analysis to assess the prognostic impact of PHE on functional outcome and mortality in patients with ICH.
METHODS: We searched major databases through December 2020 using predefined keywords. Any study using logistic regression to examine the association between PHE or its growth and functional outcome was included. We examined the overall pooled effect and conducted secondary analyses to explore the impact of individual PHE measures on various outcomes separately. Study quality was assessed by three independent raters using the Newcastle-Ottawa Scale. Odds ratios (per 1-unit increase in PHE) and their confidence intervals (CIs) were log transformed and entered into a DerSimonian-Laird random-effects meta-analysis to obtain pooled estimates of the effect.
RESULTS: Twenty studies (n = 6633 patients) were included in the analysis. The pooled effect size for overall outcome was 1.05 (95% CI 1.02-1.08; p < 0.00). For the following secondary analyses, the effect size was weak: mortality (1.01; 95% CI 0.90-1.14), functional outcome (1.04; 95% CI 1.02-1.07), both 90-day (1.06; 95% CI 1.02-1.11), and in-hospital assessments (1.04; 95% CI 1.00-1.08). The effect sizes for PHE volume and PHE growth were 1.04 (95% CI 1.01-1.07) and 1.14 (95% CI 1.04-1.25), respectively. Heterogeneity across studies was substantial except for PHE growth.
CONCLUSIONS: This meta-analysis demonstrates that PHE volume within the first 72 h after ictus has a weak effect on functional outcome and mortality after ICH, whereas PHE growth might have a slightly larger impact during this time frame. Definitive conclusions are limited by the large variability of PHE measures, heterogeneity, and different evaluation time points between studies.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Entities:  

Keywords:  Intracerebral hemorrhage; Meta-analysis; Perihematomal edema

Mesh:

Year:  2022        PMID: 35578090     DOI: 10.1007/s12028-022-01512-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.532


  57 in total

Review 1.  Spontaneous intracerebral hemorrhage.

Authors:  A I Qureshi; S Tuhrim; J P Broderick; H H Batjer; H Hondo; D F Hanley
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

Review 2.  Intracranial hemorrhage: mechanisms of secondary brain injury.

Authors:  Josephine Lok; Wendy Leung; Sarah Murphy; William Butler; Natan Noviski; Eng H Lo
Journal:  Acta Neurochir Suppl       Date:  2011

Review 3.  Targeting secondary injury in intracerebral haemorrhage--perihaematomal oedema.

Authors:  Sebastian Urday; W Taylor Kimberly; Lauren A Beslow; Alexander O Vortmeyer; Magdy H Selim; Jonathan Rosand; J Marc Simard; Kevin N Sheth
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

4.  Effects of Deferoxamine Mesylate on Hematoma and Perihematoma Edema after Traumatic Intracerebral Hemorrhage.

Authors:  Jian Yu; Qiang Yuan; Yi-Rui Sun; Xing Wu; Zhuo-Ying Du; Zhi-Qi Li; Xue-Hai Wu; Liang-Fu Zhou; Gang Wu; Jin Hu
Journal:  J Neurotrauma       Date:  2017-07-19       Impact factor: 5.269

Review 5.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.

Authors:  Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn
Journal:  Lancet Neurol       Date:  2010-01-05       Impact factor: 44.182

6.  Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.

Authors:  Ying Fu; Junwei Hao; Ningnannan Zhang; Li Ren; Na Sun; Yu-Jing Li; Yaping Yan; DeRen Huang; Chunshui Yu; Fu-Dong Shi
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

7.  Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network).

Authors:  Antonio González-Pérez; David Gaist; Mari-Ann Wallander; Gillian McFeat; Luis A García-Rodríguez
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

8.  Combatting Secondary Injury From Intracerebral Hemorrhage With Supplemental Antioxidant Therapy.

Authors:  Ashkan Shoamanesh; Aristeidis H Katsanos
Journal:  Stroke       Date:  2021-02-25       Impact factor: 7.914

9.  Reactive Oxygen Species Scavenger in Acute Intracerebral Hemorrhage Patients: A Multicenter, Randomized Controlled Trial.

Authors:  Moinay Kim; Joonho Byun; Yeongu Chung; Si Un Lee; Ji Eun Park; Wonhyoung Park; Jung Cheol Park; Jae Sung Ahn; Seungjoo Lee
Journal:  Stroke       Date:  2021-02-25       Impact factor: 7.914

Review 10.  Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage.

Authors:  Weixiang Chen; Chao Guo; Hua Feng; Yujie Chen
Journal:  Front Aging Neurosci       Date:  2021-01-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.